Lv717
5000 积分 2021-10-11 加入
The lncRNA EPIC1 suppresses dsRNA-induced type I IFN signaling and is a therapeutic target to enhance TNBC response to PD-1 inhibition
29天前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
30天前
已完结
How multispecific molecules are transforming pharmacotherapy
1个月前
已完结
Astrocytic RIPK3 exerts protective anti-inflammatory activity in mice with viral encephalitis by transcriptional induction of serpins
1个月前
已完结
Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma models
2个月前
已完结
Immunological Tolerance to Luciferase and Fluorescent Proteins using Tol Mice Enables Development of Improved Tumor Models for Investigating Immunity and Metastasis
2个月前
已完结
Microglia heterogeneity, modeling and cell-state annotation in development and neurodegeneration
4个月前
已完结
An explainable deep learning platform for molecular discovery
5个月前
已完结
Systematic reconstruction of molecular pathway signatures using scalable single-cell perturbation screens
5个月前
已完结
A humanized antibody against mucormycosis targets angioinvasion and augments the host immune response
5个月前
已完结
皖公网安备34019202002308
